PRESS RELEASE published on 05/05/2025 at 12:15, 10 months 18 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA makes declaration on number of shares and voting rights in the issued capital, meeting regulatory requirements. Details in the announcement Voting Rights Déclaration Shares Sartorius Stedim Biotech Regulatory Requirements
BRIEF published on 04/16/2025 at 14:46, 11 months 7 days ago Sartorius Stedim Biotech First Quarter 2025 Results EBITDA Sartorius Stedim Biotech Turnover 2025 Forecast Bioproduction
BRIEF published on 04/16/2025 at 07:05, 11 months 7 days ago Sartorius Stedim Biotech Reports Q1 2025 Results with Strong Growth Financial Performance Profitability Biotech Growth Q1 2025 Results Biomanufacturing Demand
PRESS RELEASE published on 04/16/2025 at 07:00, 11 months 7 days ago Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 Sartorius Stedim Biotech reports strong first quarter results for 2025 with 10.4% sales revenue growth and a full-year sales revenue guidance increase of 7% Sartorius Stedim Biotech Biopharmaceutical Industry First Quarter Results Full-year Guidance Sales Revenue Growth
BRIEF published on 04/01/2025 at 10:36, 11 months 22 days ago Sartorius Stedim Biotech Announces Share and Voting Rights Details Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 04/01/2025 at 10:33, 11 months 22 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights making up the issued capital as of March 31, 2025 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 04/01/2025 at 10:31, 11 months 22 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA announces total number of shares, theoretical voting rights, and net voting rights as of March 31, 2025 Voting Rights Capital Shares Sartorius Stedim Biotech SA Announcement
BRIEF published on 03/25/2025 at 15:40, 11 months 29 days ago Sartorius Stedim Biotech Shareholders Approve Key Resolutions Board Of Directors Leadership Changes Shareholders' Meeting Sartorius Stedim Biotech Dividend Approval
PRESS RELEASE published on 03/25/2025 at 15:35, 11 months 29 days ago Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. shareholders pass resolutions at Annual Shareholders' Meeting, elect new Board Members, and approve dividend payout. Company overview and financial calendar included Board Members Financial Calendar Shareholders' Meeting Sartorius Stedim Biotech Dividend Payout
BRIEF published on 03/05/2025 at 10:56, 1 year ago Sartorius Stedim Biotech Reports Share Capital and Voting Rights Share Capital Voting Rights Regulatory Compliance French Regulations Sartorius Stedim
Published on 03/23/2026 at 14:05, 3 hours 10 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 3 hours 15 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 4 hours 10 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 43 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 4 hours 45 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 2 hours 10 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 2 hours 33 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 2 hours 45 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 2 hours 45 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/20/2026 at 19:00, 2 days 22 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 23 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 3 days ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 23 hours ago Filing of the 2025 Universal Registration Document
